Printer Friendly Version in PDF Format (1 PDF pages)
The next meeting of the Advisory Council on Alzheimer's Research, Care, and Services will be held on Friday, January 26, 2018 from 9:00am to 5:00pm EDT. The meeting will be held at the U.S. Department of Health and Human Services, Room 800, Hubert H. Humphrey Building, 200 Independence Avenue, S.W., Washington, DC 20201, and webcast live on http://www.hhs.gov/live. Please allow 45 minutes to go through security and walk to the meeting room.
During the January meeting, the Research Subcommittee will be taking charge of the theme, focusing on the process from targets to treatments. The Council will hear speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting will also include discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates.
Public Attendance: Seating is limited. Individuals who wish to participate should send an email to napa@hhs.gov with "January 26 Meeting Attendance" in the Subject line by Thursday, January 18, 2018. Names need to be put on a list of expected attendees and forwarded to the security officers at HHS. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to federal buildings may change without notice. Each attendee needs a photo ID to gain entrance into the building.
Public Input: Time is allocated in the afternoon on the agenda to hear public comments. The time for oral comments will be limited to two (2) minutes per individual. Attendees who wish to make in-person public comments should include that information in their "January 26 Meeting Attendance" email; this information is also needed by Thursday, January 18, 2018. In lieu of in-person comments, written comments may also be submitted to be read at the meeting. All comments should be submitted for the record to share with the Advisory Council by January 19, 2018 to:
Rohini Khillan
HHS Office of the Assistant Secretary for Planning and Evaluation
Room 424E, Humphrey Building
200 Independence Avenue, SW
Washington DC, 20201
Comments may also be emailed to napa@hhs.gov. Please include your name and relevant organizational affiliation.
January 26, 2018 -- Advisory Council Meeting #27
The meeting was held on Friday, January 26, 2018, in Washington, DC. The Research Subcommittee took charge of this meeting's theme, focusing on the process from targets to treatments. The Council heard speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting also included discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates. Material available from this meeting is listed below and at https://aspe.hhs.gov/advisory-council-alzheimers-research-care-and-services-meetings#Jan2018.
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.
General Information
-
Agenda -- [HTML Version] [PDF Version]
-
Meeting Announcement -- [HTML Version] [PDF Version]
-
Meeting Summary -- [HTML Version] [PDF Version]
-
Public Comments -- [HTML Version]
Handouts
-
Care Summit Report Themes -- [PDF Version]
-
NAPA Driver Diagram Draft Examples -- [PDF Version]
-
Outline for Care Summit Final Report -- [PDF Version]
Presentation Slides
-
AbbVie's R&D Vision for Alzheimer's Disease -- [HTML Version] [PDF Version]
-
Care Summit Report -- [HTML Version] [PDF Version]
-
Clinical Subcommittee Update -- [HTML Version] [PDF Version]
-
Initiatives, Partnerships and Collaboration to Help Patients with the Highest Unmet Need: Dominantly Inherited Alzheimer's Disease Trials Unit (DIAN-TU) as a Case Example -- [HTML Version] [PDF Version]
-
Long-Term Services and Supports Committee Update -- [HTML Version] [PDF Version]
-
NAPA Driver Diagram -- [HTML Version] [PDF Version]
-
Overview of the Clinical Trial Pipeline for AD -- [HTML Version] [PDF Version]
-
Overview on NIA Preclinical Pipeline -- [HTML Version] [PDF Version]
-
Participating in an Alzheimer's Clinical Study: Perspectives on Involvement of a Person Living with Dementia and Her Study Partner -- [HTML Version] [PDF Version]
-
Progress Since October -- [HTML Version] [PDF Version]
-
Research Progress on Alzheimer's Disease and Related Dementias -- [HTML Version] [PDF Version]
-
Research Subcommittee Agenda: The Journey from Targets to Treatments -- [HTML Version] [PDF Version]